Is PFE the Best Dividend Play in Its Industry?
By their inherent nature, established pharma companies face a demand backdrop that is stable because consumers rarely cut medical spending, even in tough …
By their inherent nature, established pharma companies face a demand backdrop that is stable because consumers rarely cut medical spending, even in tough …
Stanley Druckenmiller may be best known for his role with George Soros in shorting the British pound in 1992, which famously became known as breaking the Bank …
With around $65.7 billion in net assets, Schwab’s US Dividend Equity ETF (SCHD) is one of the most popular funds among investors seeking dividend income …
The biotech market is expanding steadily as new technology makes previously impossible medical breakthroughs a reality. Global biotech is forecasted to reach …
Moderna stock plunged last month after the company said its respiratory syncytial virus shot, mRESVIA, only has 50% efficacy in preventing RSV after 18 months. …
Warren Buffett is a legend in the investing world, and generations of new investors have studied his portfolio over the years to learn how to choose individual …
The advertising industry is finally getting back on track after many companies decreased their ad spend in 2022 and 2023. London-based media holding company …
Over the last few decades, personalized medicine has transformed the healthcare industry with treatments tailored for individual patients. At the same time, …
Biotech is a volatile sector and it’s not just topsy turvy stocks that pose risks. According to data compiled by BioPharma Dive, the biotech sector laid …
Retirees have typically turned to investment vehicles that are stable and relatively safe, such as bonds or CDs. Because of the stock market’s volatility, …
German-based biotechnology company BioNTech SE (NASDAQ:BNTX) roared to great heights with its COVID-19 vaccine. As demand for these vaccines ebbed, the company …
The rise and fall of Pfizer (NYSE: PFE) over the past few years has been truly historic. At the peak of the pandemic shares nearly breached $60 before being …
It’s been a wild ride for Moderna (NASDAQ: MRNA) having traded just under $500 two years ago, about 5x higher than where it resides today. The …
Dividend stocks offer a timeless appeal, particularly for billionaires. While high-risk, high-reward strategies can be exciting, there’s something deeply …
Positive trial data is the lifeblood that fuels success in the pharmaceutical business. It’s the beacon of hope that illuminates the path to regulatory …
In the complex world of pharmaceutical research, it’s no stretch to say that intellectual property is the lifeblood of innovation and the ultimate …
Longitudinal studies of the stock market show that its behavior takes on patterns over time. For example, the market moves in a cyclical manner, and …
CureVac is a German biotechnology company that specializes in the development of messenger RNA (mRNA) vaccines and therapies. CureVac has been focused on using …
In this article, we’ll take a look at five dividend-paying large-cap companies whose businesses are all extremely profitable. And yet, while they share the …
Is Vanguard High Yield Dividend Index Fund Stock A Buy? Growth investors and income investors look at the market differently. Growth investors are focused on a …